- In April 2023, research published in JAMA Otolaryngology - Head and Neck Surgery examined Bell’s Palsy incidence among COVID-19 vaccine recipients. While randomized trials showed a higher incidence in vaccinated individuals, observational studies found no significant association. The study also indicated that Bell’s Palsy occurred more frequently during COVID-19 infection than after vaccination, with a higher risk linked to the infection itself, not the vaccine. Further research is needed to fully understand these findings and explore why some individuals develop Bell’s Palsy post-vaccination
- In July 2020, surgeons at UT Southwestern developed a groundbreaking technique for Bell’s Palsy patients, enabling more effective eye closure and corneal protection. This innovative procedure, which reinnervates eye muscles, has proven most effective for patients with paralysis lasting under 18 months. Research highlights that the technique leads to faster, more complete eye closure, marking a significant advancement in Bell’s Palsy treatment and reinforcing UT Southwestern's leadership in reconstructive surgery and medical research
- In March 2021, Fujifilm Corporation, a leading Japan-based imaging and information solutions provider, acquired Hitachi Ltd.'s diagnostic imaging business for JPY 179 billion ($1.14 billion). This strategic acquisition included Hitachi’s CT, MRI, X-ray, and ultrasound systems, aimed at strengthening Fujifilm’s medical systems division. Hitachi, known for its imaging equipment, plays a significant role in the diagnosis of Bell's Palsy, and this acquisition expands Fujifilm's capabilities in the healthcare sector
